Urine concentrations of repetitive doses of inhaled salbutamol

International Journal of Sports Medicine

Volumn 32, Issue 8, 2011, Pages 574-579

  Elers, J ^a   Pedersen, L ^a   Henninge, J ^b   Hemmersbach, P ^b   Dalhoff, K ^a   Backer, V ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b AKER UNIVERSITY HOSPITAL   (Norway)

Author keywords

asthma; beta2 agonists; doping; pharmacokinetics

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; SALBUTAMOL;

ADULT; ARTICLE; ASTHMA; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPING; DRUG ADMINISTRATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; TIME; URINE;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ALBUTEROL; ASTHMA; CASE-CONTROL STUDIES; DOPING IN SPORTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; MALE; TIME FACTORS; YOUNG ADULT;

EID: 80051470932     PISSN: 01724622     EISSN: 14393964     Source Type: Journal    
DOI: 10.1055/s-0031-1273755     Document Type: Article

References (23)

1. Anderson PJ. Pharmacokinetics of (R,S)-albuterol after aerosol inhalation in healthy adult volunteers. J Pharm Sci 1998 87 841-844 (Pubitemid 28319414)
2. Anderson SD, Argyros GJ, Magnussen H, Holzer K. Provocation by eucapnic voluntary hyperpnoea to identify exercise induced bronchoconstriction. Br J Sports Med 2001 35 344-347 (Pubitemid 32929823)
3. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005 171 912-930
4. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, Pizzichini E, Sullivan SD, Wenzel SE, Zar HJ. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008 31 143-178
5. Berges R, Segura J, Ventura R, Fitch KD, Morton AR, Farré M, Mas M, de La Torre X. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin Chem 2000 46 1365-1375
6. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, Bouglas G, Muers M, Smith D, White J. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systemic review of the literature. Health Technol Assess 2001 5 1-149
7. Carlsen KH, Anderson SD, Bjermer L, Bonini S, Brusasco V, Canonica W, Cummiskey J, Delgado L, Del Giacco SR, Drobnic F, Haahtela T, Larsson K, Palange P, Popov T, van Cauwenberge P. Exercise-induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN. Allergy 2008 63 387-403 (Pubitemid 351341832)
8. Dreborg S. The skin prick test: methodological studies and clinical applications. Linköping University, Linköping, Sweden 1987
9. Elers J, Pedersen L, Henninge J, Lund TK, Hemmersbach P, Dalhoff K, Backer V. Blood and urinary concentrations of salbutamol in asthmatic subjects. Med Sci Sports Exerc 2010 42 244-249
10. Elers J, Strandbygaard U, Pedersen L, Backer V. Daily use of salmeterol causes tolerance to bronchodilation with terbutaline in asthmatic subjects. Open Respir Med J 2010 21; 4 48-50
11. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med 2002 165 1068-1070
12. Harriss DJ, Atkinson G. International Journal of Sports Medicine Ethical Standards in Sport and Exercise Science Research. Int J Sports Med 2009 30 701-702
13. Helenius IJ, Tikkanen HO, Haahtela T. Association between type of training and risk of asthma in elite athletes. Thorax 1997 52 157-160 (Pubitemid 27086744)
14. Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol 1998 101 646-652 (Pubitemid 28228309)
15. Nysom K, Ulrik CS, Hesse B, Dirksen A. Published models and local data can bridge the gap between reference values of lung function for children and adults. Eur Respir J 1997 10 1591-1598 (Pubitemid 27311078)
16. Pichon A, Venisse N, Krupka E, Pérault-Pochat MC, Denjean A. Urinary and blood concentrations of beta-2-agonists in trained subject: comparison between routes of use. Int J Sports Med 2006 27 187-192 (Pubitemid 43384904)
17. Schweizer C, Saugy M, Kamber M. Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete. Clin J Sport Med 2004 14 312-315 (Pubitemid 39313488)
18. Sporer BC. Dose response of inhaled salbutamol on exercise performance and urine concentrations. Med Sci Sports Exerc 2008 40 149-157
19. Sporer BC. Inhaled salbutamol and doping control: effects of dose on urine concentrations. Clin J Sport Med 2008 18 282-285 (Pubitemid 351670435)
20. The Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA). 2008 available on www.ginasthma.com
21. Thomsen SF, Ulrik CS, Larsen K, Backer V. Change in prevalence of asthma in Danish children and adolescents. Ann Allergy Asthma Immunol 2004 92 506-511 (Pubitemid 39236813)
22. Ventura R, Segura J, Berges R, Fitch KD, Morton AR, Berruezo S, Jiménez C. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther Drug Monit 2000 22 277-282 (Pubitemid 30346443)
23. Yan K, Salome C, Woolcock AJ. Rapid method for measurement of bronchial responsiveness. Thorax 1983 38 760-765 (Pubitemid 13019506)